Literature DB >> 12203778

Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis.

Xin Mao1, Debra Lillington, Fiona Child, Robin Russell-Jones, Bryan Young, Sean Whittaker.   

Abstract

To investigate genetic alterations in primary cutaneous B-cell lymphomas (PCBCLs), we have analyzed 29 cases of PCBCL. Comparative genomic hybridization showed chromosome imbalances (CIs) in 12 cases (41%). The mean number of CIs per sample was 2.05 +/- 2.97, with gains (1.48 +/- 2.38) more frequent than losses (0.56 +/- 1.40). The common regions of gains were 18/18q (50%), 7/7p (42%), 3/3q (33%), 20 (33%), 1p (25%), 12/12q (25%), and 13/13q (25%), whereas loss of 6q was frequent (42%). Among the different subsets of PCBCLs, CI was seen in 50% of diffuse large-cell lymphomas (DLCLs), 33% of marginal zone lymphomas, and 8% of follicle center cell lymphomas and unclassified lymphomas. A similar pattern of CI was observed in these lymphomas, but loss of 6q and gains of 3/3q were present only in DLCLs. Microarray-based genomic analysis of four DLCL cases identified oncogene gains of SAS/CDK4 (12q13.3) in three cases and MYCL1 (1p34.3), MYC (8q24), FGFR2 (10q26), BCL2 (18q21.3), CSE1L (20q13), and PDGFB (22q12-13) in two cases, whereas losses of AKT1 (14q32.3), IGFR1 (15q25-26), and JUNB (19p13.2) were identified in three cases, and losses of FGR (1p36), ESR (6q25.1), ABL1 (9q34.1), TOP2A (17q21-22), ERBB2 (17q21.2), CCNE1 (19q13.1), and BCR (22q11) were each identified in two cases. In addition, real-time-polymerase chain reaction detected amplification of BCL2 in 5 of 29 cases. These findings suggest that there are complex but consistent genetic alterations associated with the pathogenesis of PCBCLs. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203778     DOI: 10.1002/gcc.10104

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha.

Authors:  Ashish Lal; Tomoko Kawai; Xiaoling Yang; Krystyna Mazan-Mamczarz; Myriam Gorospe
Journal:  EMBO J       Date:  2005-04-28       Impact factor: 11.598

Review 2.  MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development.

Authors:  Katie Podshivalova; Daniel R Salomon
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 3.  Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms.

Authors:  Alexandra Papoudou-Bai; Eleftheria Hatzimichael; Alexandra Barbouti; Panagiotis Kanavaros
Journal:  Clin Exp Med       Date:  2016-09-06       Impact factor: 3.984

4.  Alternative lengthening of telomeres: recurrent cytogenetic aberrations and chromosome stability under extreme telomere dysfunction.

Authors:  Despoina Sakellariou; Maria Chiourea; Christina Raftopoulou; Sarantis Gagos
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

Review 5.  What's new in karyotyping? The move towards array comparative genomic hybridisation (CGH).

Authors:  Thomy J L de Ravel; Koen Devriendt; Jean-Pierre Fryns; Joris R Vermeesch
Journal:  Eur J Pediatr       Date:  2007-03-20       Impact factor: 3.183

Review 6.  [Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].

Authors:  C Lamos; E Dippel
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

Review 7.  CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

Authors:  Ming-Chung Jiang
Journal:  Tumour Biol       Date:  2016-09-05

8.  Lkb1 deletion in murine B lymphocytes promotes cell death and cancer.

Authors:  George P Souroullas; Yuri Fedoriw; Louis M Staudt; Norman E Sharpless
Journal:  Exp Hematol       Date:  2017-04-21       Impact factor: 3.084

9.  GPC5 is a possible target for the 13q31-q32 amplification detected in lymphoma cell lines.

Authors:  Wei Yu; Jun Inoue; Issei Imoto; Yoshinobu Matsuo; Abraham Karpas; Johji Inazawa
Journal:  J Hum Genet       Date:  2003-04-29       Impact factor: 3.172

10.  Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas.

Authors:  Marc-Antoine Belaud-Rotureau; Virginie Marietta; Beatrice Vergier; Guillaume Mainhaguiet; Michelle Turmo; Yamina Idrissi; Jacky Ferrer; Marie Beylot-Barry; Pierre Dubus; Jean-Philippe Merlio
Journal:  Virchows Arch       Date:  2008-03-01       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.